Style | Citing Format |
---|---|
MLA | Mohammadikhanaposhtani M, et al.. "Design, Synthesis and Cytotoxicity of Novel Coumarin-1,2,3-Triazole-1,2,4-Oxadiazole Hybrids As Potent Anti-Breast Cancer Agents." Letters in Drug Design and Discovery, vol. 16, no. 7, 2019, pp. 818-824. |
APA | Mohammadikhanaposhtani M, Fahimi K, Karimpourrazkenari E, Safavi M, Mahdavi M, Saeedi M, Akbarzadeh T (2019). Design, Synthesis and Cytotoxicity of Novel Coumarin-1,2,3-Triazole-1,2,4-Oxadiazole Hybrids As Potent Anti-Breast Cancer Agents. Letters in Drug Design and Discovery, 16(7), 818-824. |
Chicago | Mohammadikhanaposhtani M, Fahimi K, Karimpourrazkenari E, Safavi M, Mahdavi M, Saeedi M, Akbarzadeh T. "Design, Synthesis and Cytotoxicity of Novel Coumarin-1,2,3-Triazole-1,2,4-Oxadiazole Hybrids As Potent Anti-Breast Cancer Agents." Letters in Drug Design and Discovery 16, no. 7 (2019): 818-824. |
Harvard | Mohammadikhanaposhtani M et al. (2019) 'Design, Synthesis and Cytotoxicity of Novel Coumarin-1,2,3-Triazole-1,2,4-Oxadiazole Hybrids As Potent Anti-Breast Cancer Agents', Letters in Drug Design and Discovery, 16(7), pp. 818-824. |
Vancouver | Mohammadikhanaposhtani M, Fahimi K, Karimpourrazkenari E, Safavi M, Mahdavi M, Saeedi M, et al.. Design, Synthesis and Cytotoxicity of Novel Coumarin-1,2,3-Triazole-1,2,4-Oxadiazole Hybrids As Potent Anti-Breast Cancer Agents. Letters in Drug Design and Discovery. 2019;16(7):818-824. |
BibTex | @article{ author = {Mohammadikhanaposhtani M and Fahimi K and Karimpourrazkenari E and Safavi M and Mahdavi M and Saeedi M and Akbarzadeh T}, title = {Design, Synthesis and Cytotoxicity of Novel Coumarin-1,2,3-Triazole-1,2,4-Oxadiazole Hybrids As Potent Anti-Breast Cancer Agents}, journal = {Letters in Drug Design and Discovery}, volume = {16}, number = {7}, pages = {818-824}, year = {2019} } |
RIS | TY - JOUR AU - Mohammadikhanaposhtani M AU - Fahimi K AU - Karimpourrazkenari E AU - Safavi M AU - Mahdavi M AU - Saeedi M AU - Akbarzadeh T TI - Design, Synthesis and Cytotoxicity of Novel Coumarin-1,2,3-Triazole-1,2,4-Oxadiazole Hybrids As Potent Anti-Breast Cancer Agents JO - Letters in Drug Design and Discovery VL - 16 IS - 7 SP - 818 EP - 824 PY - 2019 ER - |